This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Wayne State University. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hayward, CA (US) (2016 - 2019)
- Detroit, MI (US) (2020)
- New Hyde Park, NY (US) (2022)
Company Filing History:
4 out of 3,696 
4 out of 603 
Years Active: 2016-2022
Title: Anupa R Menjoge: Innovator in Dendrimer Nanotechnology
Introduction
Anupa R Menjoge, based in Hayward, California, is an accomplished inventor with a portfolio of four patents focusing on innovative applications in dendrimer nanotechnology. His work primarily emphasizes the development of injectable hydrogels and nanodevices that enhance therapeutic delivery and imaging.
Latest Patents
Menjoge's notable patents include the invention of injectable dendrimer hydrogel nanoparticles. These particles, ranging in size from 5 nm to 10 μm, consist of a PAMAM dendrimer with asymmetrical peripheral end groups, allowing for improved drug conjugation and hydrogel formation. The hydrogels created from these nanoparticles are particularly suitable for injectable delivery systems and ocular treatments.
Another significant invention by Menjoge involves dendrimer-based nanodevices designed for targeted therapeutic and imaging applications. These nanodevices employ a PAMAM dendrimer or multiarm PEG polymer linked to therapeutically active agents through disulfide bonds. This innovative approach facilitates the site-specific delivery of medication, thereby improving treatment efficacy.
Career Highlights
Throughout his distinguished career, Menjoge has contributed significantly to advancements in nanomedicine. He has had associations with reputable institutions, including Wayne State University and the United States Department of Health and Human Services, where he engaged in pioneering research and development.
Collaborations
Menjoge has collaborated with esteemed colleagues such as Kannan Rangaramanujam and Sujatha Kannan. Their collective expertise has fostered a collaborative environment that encourages innovation and the pursuit of groundbreaking research.
Conclusion
Anupa R Menjoge's contributions to the field of nanotechnology, particularly in the development of dendrimer-based drugs and delivery systems, have positioned him as a leading inventor in this domain. His patents reflect a commitment to enhancing therapeutic outcomes and advancing medical technology, making a significant impact in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile